New Leptospirosis Data Have Been Reported by Investigators at Razi Vaccine and Serum Research Institute (Immunological Characterization of Recombinant Outer Membrane Loa22 Protein of Local Pathogenic Leptospira Serovars).

Researchers at the Razi Vaccine and Serum Research Institute in Karaj, Iran, have conducted a study on the immunological characteristics of a recombinant protein from local pathogenic Leptospira serovars. The study focused on the potential of this protein to induce humoral and cellular immunity in mice, with promising results in terms of antibody production and cytokine levels. The findings suggest that this protein could be used as a marker for diagnosing leptospirosis and potentially contribute to the development of an effective vaccine against the disease. [Extracted from the article]